Document is current
Any future updates will be listed below
-
Authors
Reetz, Shelley https://orcid.org/0000-0003-0818-2753
Clarke, Gregory
Weersing, Robin
Amir, Nader
Dickerson, John
Lynch, Frances L.
Leo, Michael C.
Rawlings, Andreea M.
Lee, Mi H.
Gille, Sara
-
Funding
Funding for this research was provided by:
National Institute of Mental Health (5R01MH101118)
- License Information
-
More Information
Article History
Received: 12 August 2019
Accepted: 20 September 2019
First Online: 22 October 2019
Ethics approval and consent to participate
: Ethics approval was obtained from the Kaiser Permanente Northwest (KPNW) Institutional Review Board (reference no. 1392726–51). This approval is reviewed and renewed annually. Verbal informed consent/assent will be obtained from each minor participant and a legal guardian.
: Not applicable.
: Dr. Amir was formerly a part owner of Cognitive Retraining Technologies, LLC (“CRT”), a company that marketed anxiety relief products. Dr. Amir’s ownership interest in CRT was extinguished on January 29, 2016, when CRT was acquired by another entity. Dr. Amir has an interest in royalty income generated by the marketing of anxiety relief products by this entity.
